Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC

Background: Non–small cell lung cancer (NSCLC) is highly malignant with driver somatic mutations and genomic instability. Long non-coding RNAs (lncRNAs) play a vital role in regulating these two aspects. However, the identification of somatic mutation-derived, genomic instability-related lncRNAs (GI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiangzhe, Liu, Xicheng, Chen, Zhinan, Zhang, Sihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382191/
https://www.ncbi.nlm.nih.gov/pubmed/35991889
http://dx.doi.org/10.3389/fphar.2022.937531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382191/
https://www.ncbi.nlm.nih.gov/pubmed/35991889
http://dx.doi.org/10.3389/fphar.2022.937531

Ejemplares similares